Panitumumab with capecitabine and oxaliplatin (CAPOX) followed by

WITHDRAWN · PHASE2 · Rectal Cancer, Neoplasm Metastasis

Protocol closed based on new (and as yet unpublished) information from a phase II clinical trial.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.